Logo image of BHK

BLACKROCK CORE BOND TRUST (BHK) Stock Price, Quote, News and Overview

NYSE:BHK - New York Stock Exchange, Inc. - US09249E1010 - Currency: USD

10.4  +0.04 (+0.39%)

After market: 10.24 -0.16 (-1.54%)

Fundamental Rating

2

Overall BHK gets a fundamental rating of 2 out of 10. We evaluated BHK against 0 industry peers in the Unkown industry. BHK has a bad profitability rating. Also its financial health evaluation is rather negative. BHK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BHK had positive earnings in the past year.
BHK had a positive operating cash flow in the past year.
Of the past 5 years BHK 4 years were profitable.
Of the past 5 years BHK 4 years had a positive operating cash flow.
BHK Yearly Net Income VS EBIT VS OCF VS FCFBHK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

The 3 year average ROIC (2.64%) for BHK is below the current ROIC(2.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.87%
ROE 9.29%
ROIC 2.68%
ROA(3y)-4.45%
ROA(5y)1.39%
ROE(3y)-8.26%
ROE(5y)0.56%
ROIC(3y)2.64%
ROIC(5y)2.58%
BHK Yearly ROA, ROE, ROICBHK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Profit Margin of BHK has declined.
In the last couple of years the Operating Margin of BHK has declined.
BHK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 58.61%
PM (TTM) 106.22%
GM 59.6%
OM growth 3Y-11.07%
OM growth 5Y-4.99%
PM growth 3Y-22.32%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-4.95%
BHK Yearly Profit, Operating, Gross MarginsBHK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, BHK has about the same amount of shares outstanding.
The number of shares outstanding for BHK has been increased compared to 5 years ago.
The debt/assets ratio for BHK has been reduced compared to a year ago.
BHK Yearly Shares OutstandingBHK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
BHK Yearly Total Debt VS Total AssetsBHK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

Based on the Altman-Z score of 0.51, we must say that BHK is in the distress zone and has some risk of bankruptcy.
BHK has a debt to FCF ratio of 2.23. This is a good value and a sign of high solvency as BHK would need 2.23 years to pay back of all of its debts.
BHK has a Debt/Equity ratio of 0.51. This is a neutral value indicating BHK is somewhat dependend on debt financing.
Although BHK does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 2.23
Altman-Z 0.51
ROIC/WACCN/A
WACCN/A
BHK Yearly LT Debt VS Equity VS FCFBHK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.05 indicates that BHK may have some problems paying its short term obligations.
BHK has a Quick Ratio of 0.05. This is a bad value and indicates that BHK is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
BHK Yearly Current Assets VS Current LiabilitesBHK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

BHK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 127.20%, which is quite impressive.
BHK shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.34% yearly.
The Revenue has grown by 8.95% in the past year. This is quite good.
Measured over the past years, BHK shows a small growth in Revenue. The Revenue has been growing by 0.26% on average per year.
EPS 1Y (TTM)127.2%
EPS 3Y-19.34%
EPS 5YN/A
EPS Q2Q%201.16%
Revenue 1Y (TTM)8.95%
Revenue growth 3Y3.89%
Revenue growth 5Y0.26%
Sales Q2Q%5.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHK Yearly Revenue VS EstimatesBHK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.20, the valuation of BHK can be described as reasonable.
Compared to an average S&P500 Price/Earnings ratio of 28.87, BHK is valued rather cheaply.
Industry RankSector Rank
PE 10.2
Fwd PE N/A
BHK Price Earnings VS Forward Price EarningsBHK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.16
EV/EBITDA N/A
BHK Per share dataBHK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.88%, BHK is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.46, BHK pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.88%

5.2 History

The dividend of BHK has a limited annual growth rate of 2.78%.
BHK has paid a dividend for at least 10 years, which is a reliable track record.
BHK has decreased its dividend recently.
Dividend Growth(5Y)2.78%
Div Incr Years1
Div Non Decr Years1
BHK Yearly Dividends per shareBHK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BHK pays out 87.49% of its income as dividend. This is not a sustainable payout ratio.
DP87.49%
EPS Next 2YN/A
EPS Next 3YN/A
BHK Yearly Income VS Free CF VS DividendBHK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M
BHK Dividend Payout.BHK Dividend Payout, showing the Payout Ratio.BHK Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK CORE BOND TRUST

NYSE:BHK (4/29/2025, 1:48:14 PM)

After market: 10.24 -0.16 (-1.54%)

10.4

+0.04 (+0.39%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners20.69%
Inst Owner Change0.1%
Ins OwnersN/A
Ins Owner Change0.17%
Market Cap562.85M
Analysts45
Price TargetN/A
Short Float %0.15%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield 7.88%
Yearly Dividend0.9
Dividend Growth(5Y)2.78%
DP87.49%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.0746)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.2
Fwd PE N/A
P/S 10.82
P/FCF 4.16
P/OCF 4.16
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)1.02
EY9.81%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.5
FCFY24.02%
OCF(TTM)2.5
OCFY24.02%
SpS0.96
BVpS10.99
TBVpS10.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.87%
ROE 9.29%
ROCE 5.11%
ROIC 2.68%
ROICexc 2.69%
ROICexgc 2.71%
OM 58.61%
PM (TTM) 106.22%
GM 59.6%
FCFM 259.9%
ROA(3y)-4.45%
ROA(5y)1.39%
ROE(3y)-8.26%
ROE(5y)0.56%
ROIC(3y)2.64%
ROIC(5y)2.58%
ROICexc(3y)2.64%
ROICexc(5y)2.58%
ROICexgc(3y)2.67%
ROICexgc(5y)2.61%
ROCE(3y)5.18%
ROCE(5y)4.77%
ROICexcg growth 3Y1.61%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y1.76%
ROICexc growth 5Y-1.02%
OM growth 3Y-11.07%
OM growth 5Y-4.99%
PM growth 3Y-22.32%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-4.95%
F-Score7
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 2.23
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.89
Cash Conversion N/A
Profit Quality 244.69%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 0.51
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)127.2%
EPS 3Y-19.34%
EPS 5YN/A
EPS Q2Q%201.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.95%
Revenue growth 3Y3.89%
Revenue growth 5Y0.26%
Sales Q2Q%5.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.92%
EBIT growth 3Y-7.61%
EBIT growth 5Y-4.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y70.3%
FCF growth 3Y84.79%
FCF growth 5Y50.99%
OCF growth 1Y70.3%
OCF growth 3Y84.79%
OCF growth 5Y50.99%